Retrospective Study of the Impact of SARS-CoV-2 Infection on Asthma Control in Children

Jaqueline Abdul-Razzak1,2, Mihaela Ionescu3, Radu Diaconu2

  • 1Doctoral School, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.

PubMed

Insights

COVID-19 infection in asthmatic children can cause lasting lung function changes and persistent symptoms. Regular medical check-ups and tailored asthma treatment are crucial for managing these long-term effects.

Area of Science:

  • Pediatric Pulmonology
  • Infectious Diseases
  • Allergy and Immunology

Background:

  • Asthmatic children are a vulnerable population for respiratory infections.
  • The impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on pediatric asthma is not fully understood.
  • Long-term respiratory sequelae post-COVID-19 in children with asthma require investigation.

Purpose of the Study:

  • To analyze the influence of SARS-CoV-2 infection on lung function and symptoms in pediatric asthma patients.
  • To evaluate changes in asthma treatment and control following COVID-19.
  • To identify long-term respiratory effects in asthmatic children post-SARS-CoV-2 infection.

Main Methods:

  • Retrospective analysis of pediatric asthma patients (0-17 years) with and without SARS-CoV-2 infection (March 2020-July 2024).
  • Data collected included demographics, allergies, exacerbations, exhaled nitric oxide, ventilatory function, and asthma control (GINA assessment).
  • Statistical analysis using Mann-Whitney U, Kruskal-Wallis H, and Chi-Square tests.

Main Results:

  • Increased incidence of SARS-CoV-2 cases observed in 2022 compared to 2020-2021.
  • Statistically significant increases in exhaled nitric oxide (p < 0.0005) and exacerbations (p < 0.0005) in SARS-CoV-2 infected asthmatic children.
  • Significant differences in ventilatory function (p < 0.05) were noted between infected and non-infected asthmatic children.

Conclusions:

  • Persistent cough and altered ventilatory tests post-SARS-CoV-2 infection are significant findings in pediatric asthma.
  • Periodic medical evaluations are essential for monitoring asthmatic children after COVID-19.
  • Individualized therapeutic regimens are necessary to manage post-COVID-19 respiratory complications in pediatric asthma.

Related Concept Videos

Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.5K
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
343
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Lung Capacity01:47

Lung Capacity

The air in the lungs is measured in volumes and capacities. Lung volume measures reflect the amount of air taken in, released, or left over after a lung function, like a single inhalation. Lung capacity measures are sums of two or more lung volume measures.
49.2K